Steroid Injection for Adhesive Capsulitis
- Conditions
- Adhesive Capsulitis
- Interventions
- Registration Number
- NCT04364425
- Lead Sponsor
- Taipei Veterans General Hospital, Taiwan
- Brief Summary
This study was conducted to compare the efficacy of hydrodilatation with low dose steroid with high dose steroid for treating adhesive capsulitis.
- Detailed Description
Design: a prospective, double-blinded, randomized, clinical trial
Patient and methods:
Patients with adhesive capsulitis for at least 3 months were enrolled and randomly allocated into group 1 (hydrodilatation with low dose steroid ) and group 2 (hydrodilatation with high dose steroid). The patients were evaluated before treatment and were reevaluated 0, 6, and 12 weeks after the beginning of the treatment. Outcomes measures included a pain scale (visual analog scale), range of motion, Constant shoulder score, Shoulder Pain And Disability Index
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- clinical diagnosis of adhesive capsulitis
- a duration of complaints more than 3 months
- a reduction in passive range of motion in at least 2 of the following: forward flexion, abduction, or external rotation of the affected shoulder of more than 30 degree compared with the other side.
- prior manipulation of the affected shoulder under anesthesia;
- other conditions involving the shoulder ( rheumatoid arthritis, Hill-Sachs lesions, osteoarthritis, damage to the glenohumeral cartilage,osteoporosis, or malignancies in the shoulder region);
- neurologic deficits affecting shoulder function in normal daily activities;
- shoulder pain caused by cervical radiculopathy
- a history of drug allergy to hyaluronic acid;
- pregnancy or lactation;
- received injection into the affected shoulder during the preceding 3 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description low dose steroid Normal saline patient received ultrasound-guided 40mg triamcinolone + 4cc xylocaine + 12cc NS high dose steroid Normal saline patient received ultrasound-guided 10mg triamcinolone + 4cc xylocaine + 15cc NS low dose steroid lidocaine hydrochloride patient received ultrasound-guided 40mg triamcinolone + 4cc xylocaine + 12cc NS low dose steroid Triamcinolone Acetonide patient received ultrasound-guided 40mg triamcinolone + 4cc xylocaine + 12cc NS high dose steroid Triamcinolone Acetonide patient received ultrasound-guided 10mg triamcinolone + 4cc xylocaine + 15cc NS high dose steroid lidocaine hydrochloride patient received ultrasound-guided 10mg triamcinolone + 4cc xylocaine + 15cc NS
- Primary Outcome Measures
Name Time Method change in pain intensity 0, 6, 12 wks. pain intensity was measured by visual analog scale (0-10)
- Secondary Outcome Measures
Name Time Method change in glenohumeral joint range of motion 0, 6, 12 wks. Shoulder flexion, abduction, external rotation and internal rotation were measured with goniometer with patient in supine position.
change in Shoulder Pain And disability index 0, 6, 12 wks. The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use. The SPADI takes 5 to 10 minutes for a patient to complete and is the only reliable and valid region-specific measure for the shoulder.
Trial Locations
- Locations (1)
Taipei veteran general hospital
🇨🇳Taipei, Taiwan